Spontaneous Hematoma and Covid-19: Diagnosis and Management, A Case Report

H Brahimi1,3, D Taleb, A2,3 and Benabdellah1,3*

Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Case Report Volume 5 Issue 11

Spontaneous Hematoma and Covid-19: Diagnosis and Management, A Case Report

H Brahimi^1,3, MH Labdouni², D Taleb A^2,3 and Benabdellah^1,3*

¹Infectious Disease Department, University Hospital Center, Algeria
²University Ahmed Benbella, Faculty of Medicine, Oran-1, Algeria
³Radiology Department, University Hospital Center, Algeria
⁴Faculty of Medicine, University of Abu Bakr Belkaid, Tlemcen, Algeria

*Corresponding Author: Benabdellah, Infectious Disease Department, University Hospital Center, Algeria.

Received: October 04, 2021; Published: October 18, 2021

Reprints View PDF Related Articles

Abstract

The aim of our presentation is to warn against these bleeding complications and to discuss their etiological diagnosis and management.

Keywords: Covid-19; Bleeding; Chronic Renal Failure

References

BELKIN BA and VINE HS. “Spontaneous renal rupture: evaluation by computerized tomography”. Journal of Urology 138 (1987): 120-122.
BELVILLE JS., et al. “Spontaneous perinephric and subcapsular renal hemorrhage: evaluation with CT, US, and angiography”. Radiology 172 (1989): 733-738.
BRKOVIC D., et al. “Aetiology, diagnosis and management of spontaneous perirenal haematomas”. European Urology 29 (1996): 302-307.
KENDALL AR., et al. “Spontaneous subcapsular renal hematoma: diagnosis and management”. Journal of Urology 139 (1988): 246-250.
MACKENZIE AR. “Spontaneous subcapsular renal hematoma: report of a case misdiagnosed as acute appendicitis”. Journal of Urology 84 (1960): 243.
MANTEL A., et al. “Hématomes spontanés de la loge rénale: stratégie diagnostique et thérapeutique”. Progress in Urology 6 (1996): 409-414.
MAZEMAN E., et al. “Apport de la tomodensitométrie et de l'échographie dans le diagnostic des hématomes sous capsulaires du rein”. Journal of Radiology 65 (1984): 651-654.
ZAGORIA RJ., et al. “Spontaneous perinephric hemorrhage: imaging and management”. Journal of Urology 145 (1991): 468-471.
ZHANG JQ., et al. “Etiology of spontaneous perirenal hemorrhage: a meta-analysis”. Journal of Urology 167 (2002): 1593-1596.
Hirsh J., et al. “Guide to anticoagulant therapy: Heparin: A statement for healthcare professionals from the American heart association”. Circulation 103 (20001): 2994-3018.
Warkentin TE., et al. “Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin”. The New England Journal of Medicine 332 (1991): 1330-1335.
Thorevska N., et al. “Anticoagulation in hospitalized patients with renal insufficiency: A comparison of bleeding rates with unfractionated heparin vs enoxaparin”. Chest 125 (2004): 856-863.
Lim W., et al. “Safety and efficacy of low molecular weight heparins for hemodialysis in patients with end-stage renal failure: A meta-analysis of randomized trials”. Journal of the American Society of Nephrology 15 (2004): 3192-3206.
“Rhabdomyolyse: une revue de la literature”. Netherlands Journal of Medicine 67 (2009): 272-283.
Runnstrom M., et al. “Rhabdomyolyse induite par la grippe”. Représentant de l'affaire BMJ 11 (2018).
Chen LL., et al. “Rhabdomyolyse associée à une insuffisance rénale aiguë chez les patients atteints d'un syndrome respiratoire aigu sévère”. International Journal of Clinical Practice 59 (2005): 1162-1166.
Puelles VG., et al. “Tropisme multiorganique et rénal du SARS-CoV-2”. The New England Journal of Medicine 383 (2020): 590-592.
Jin M and Tong Q. “La rhabdomyolyse comme complication tardive potentielle associée au COVID-19”. Emerging Infectious Diseases 26 (2020): 1618-1620.
International Union of Phlebology (IPU). “Doppler ultrasound examination of the veins of the lower limbs in chronic venous disease - Consensus text”. Phlebology 3 (2007): 271-279.
Panigada M., et al. “Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis”. Journal of Thrombosis and Haemostasis 18 (2020): 1738-1742.
Ranucci M., et al. “The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome”. Journal of Thrombosis and Haemostasis 18 (2020): 1747-1751.
Erdinc B., et al. “Hematological manifestations and complications of COVID-19”. Advances in Clinical and Experimental Medicine 1 (2021): 101-107.
Nahum J., et al. “Venous thrombosis among critically ill patients with coronavirus disease 2019 (COVID-19)”. JAMA Newton Open5 (2020).
Llitjos JF., et al. “High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients”. Journal of Thrombosis and Haemostasis 18 (2020): 1743-1746.
Helms J., et al. “High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study”. Intensive Care Medicine 46 (2020): 1089-1098.
Klok FA., et al. “Incidence of thrombotic complications in critically ill ICU patients with COVID-19”. Thrombosis Research 191 (2020): 145-147.
Bilaloglu S., et al. “Thrombosis in hospitalized patients with COVID-19 in a New York City Health System”. JAMA 8 (2020): 799-801.
Wichmann D., et al. “Autopsy findings and venous thrombo embolism in patients with COVID-19”. Annals of Internal Medicine (2020).

Citation

Citation: Benabdellah.,et al. “Spontaneous Hematoma and Covid-19: Diagnosis and Management, A Case Report”.Acta Scientific Medical Sciences 5.11 (2021): 76-80.

Copyright

Copyright: © 2021 Benabdellah.,et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.